SNAP Brands Ventures Ltd. has signed an MOU to fully acquire a company using breath biomarker analysis technology that provides personalized Prenatal / Postpartum smoke cessation services in the United States.
The company that SNAP intends to purchase will add breath analysis biomarker technology into their existing voice based analysis technology, furthering their ability to provide personalized product and / or therapeutic recommendations that can help the user improve their overall health and empower positive behavioural changes.
Dino Minichiello, CEO of Snap Brands: “With almost two decades of profitability, this Canadian world-renowned College fits well with our overall SNAP Brands model of integrating traditional and cutting-edge health and medical practices in an effort to increase the global availability of sustainable healthcare.” The Canadia
Snap Brands has a leading capital fund group committed to the success of Snap Brands evolution. Alpha Blue Ocean (ABO) is a pioneer in alternative finance providing innovative financing solutions for companies across the globe, particularly in the medical innovation sector where it has led the alternative financing market in Europe. I
SNAP Brands Ventures Ltd. and Sonde Health Agree to Develop Vocal Biomarker Platform for SNAP Brands Customers
Sonde Health is contributing its patented vocal biomarker technology and talented team in a three-phase development program. SNAP intends to create its own unique IP from the health analysis platform. The platform utilized by SNAP is for general health and specifically targeted health conditions that correlate with the ÜrSTAXTM high-
Snap Brands is combining a direct-to-consumer approach along with artificial intelligence and machine learning, which has the potential to turn your smartphone into your lifeline for maximizing your quality of life by guiding real-world changes to better yourself and your overall health.